Skip to main content
Top
Published in: BMC Health Services Research 5/2016

Open Access 01-08-2016 | Debate

Economic evaluation of health promotion for older people-methodological problems and challenges

Authors: Kai Huter, Ewa Kocot, Katarzyna Kissimova-Skarbek, Katarzyna Dubas-Jakóbczyk, Heinz Rothgang

Published in: BMC Health Services Research | Special Issue 5/2016

Login to get access

Abstract

Background

The support of health promotion activities for older people gains societal relevance in terms of enhancing the health and well-being of older people with a view to the efficient use of financial resources in the healthcare sector. Health economic evaluations have become an important instrument to support decision-making processes in many countries. Sound evidence on the cost-effectiveness of health promotion activities would encourage support for the implementation of health promotion activities for older people. This debate article discusses to what extent economic evaluation techniques are appropriate to support decision makers in the allocation of resources regarding health promotion activities for older people. We address the problem that the economic evaluation of these interventions is hampered by methodological obstacles that limit comparability, e.g. with economic evaluations of curative measures. Our central objective is to describe and discuss the specific problems and challenges entailed in the economic evaluation of health promotion activities especially for older people with regard to their usefulness for informing decision making processes.

Discussion

Beyond general problems concerning the economic evaluation of health promotion, our discussion focusses on problems that pertain to the analysis of cost and outcomes of health promotion interventions for older people. With regard to costs these are general problems of economic evaluations, namely the actual implementation of a societal perspective, the appropriate measurement and valuation of informal caregiver time, the measurement and valuation of productivity costs and costs incurred in added years of life. The main problems concerning the identification and measurement of outcomes are related to the identification of outcome parameters that, firstly, adequately reflect the broad effects of health promotion interventions, especially social benefits that gain importance for older people, and secondly, ensure a comparability of effects across different age groups. In particular, the limitations of the widely used QALY for older people are discussed and recently developed alternatives are presented.

Conclusions

The key conclusion of the article is that a comparison of the effects of different health promotion initiatives between different age groups by means of economic evaluation is not recommendable. Taking into account the complex outcomes of health promotion interventions it has to be accepted that the outcomes of these interventions will often not be comparable with clinical interventions and have to be assessed differently.
Literature
1.
go back to reference Westerhout E. Population ageing and health care expenditure growth. In: International Handbook on Ageing and Public Policy. Cheltenham & Northampton: Edward Elgar; 2014. p. 178–90. Westerhout E. Population ageing and health care expenditure growth. In: International Handbook on Ageing and Public Policy. Cheltenham & Northampton: Edward Elgar; 2014. p. 178–90.
2.
go back to reference Mathar T, Jansen YJFM. Health Promotion and Prevention Programmes in Practice: How Patients’ Health Practices Are Rationalised, Reconceptualised and Reorganised. Bielefeld: transcript; 2010. Mathar T, Jansen YJFM. Health Promotion and Prevention Programmes in Practice: How Patients’ Health Practices Are Rationalised, Reconceptualised and Reorganised. Bielefeld: transcript; 2010.
3.
go back to reference Drummond MF, Sculpher MJ, Torrance GW, O’Brian BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford/New York: Oxford University Press; 2005. Drummond MF, Sculpher MJ, Torrance GW, O’Brian BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. Oxford/New York: Oxford University Press; 2005.
4.
go back to reference Edlin R. Assessing the cost-effectiveness of therapies for older people. In: Harper S, Hamblin K, editors. International Handbook on Ageing and Public Policy. Cheltenham & Northampton: Edward Elgar; 2014. p. 167–77. Edlin R. Assessing the cost-effectiveness of therapies for older people. In: Harper S, Hamblin K, editors. International Handbook on Ageing and Public Policy. Cheltenham & Northampton: Edward Elgar; 2014. p. 167–77.
5.
go back to reference McDaid D, Sassi F, Merkur S. Supporting effective and efficient policies: the role of economic analysis. In: McDaid D, Sassi F, Merkur S, editors. Promoting Health, Preventing Disease. The economic case, European Observatory on Health Systems and Policies Series. New York: Open University Press; 2015. p. 19–31. McDaid D, Sassi F, Merkur S. Supporting effective and efficient policies: the role of economic analysis. In: McDaid D, Sassi F, Merkur S, editors. Promoting Health, Preventing Disease. The economic case, European Observatory on Health Systems and Policies Series. New York: Open University Press; 2015. p. 19–31.
7.
go back to reference World Health Organization. Ottawa Charter for Health Promotion. World Health Organization: Geneva; 1986. World Health Organization. Ottawa Charter for Health Promotion. World Health Organization: Geneva; 1986.
8.
go back to reference Cohen D. Health promotion and cost-effectiveness. Health Promot Int. 1994;9:281–7.CrossRef Cohen D. Health promotion and cost-effectiveness. Health Promot Int. 1994;9:281–7.CrossRef
9.
go back to reference Edwards RT, Charles JM, Lloyd-Williams H. Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues. BMC Public Health. 2013;13:1001.CrossRefPubMedPubMedCentral Edwards RT, Charles JM, Lloyd-Williams H. Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues. BMC Public Health. 2013;13:1001.CrossRefPubMedPubMedCentral
10.
go back to reference Hale J. What contribution can health economics make to health promotion? Health Promot Int. 2000;15:341–8.CrossRef Hale J. What contribution can health economics make to health promotion? Health Promot Int. 2000;15:341–8.CrossRef
11.
go back to reference Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A. Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations. Health Policy. 2009;93:85–92.CrossRefPubMed Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, Rice N, Sculpher M, Sowden A. Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations. Health Policy. 2009;93:85–92.CrossRefPubMed
12.
go back to reference Nutbeam D. Evaluating health promotion—progress, problems and solutions. Health Promot Int. 1998;13:27–44.CrossRef Nutbeam D. Evaluating health promotion—progress, problems and solutions. Health Promot Int. 1998;13:27–44.CrossRef
13.
go back to reference Richardson J. Economic evaluation of health promotion: friend or foe? Aust N Z J Public Health. 1998;22:247–53.CrossRefPubMed Richardson J. Economic evaluation of health promotion: friend or foe? Aust N Z J Public Health. 1998;22:247–53.CrossRefPubMed
14.
go back to reference de Salazar L, Jackson S, Shiell A, Rice M. Guide to Economic Evaluation in Health Promotion. Washington, D.C: Pan American Health Organization; 2007. de Salazar L, Jackson S, Shiell A, Rice M. Guide to Economic Evaluation in Health Promotion. Washington, D.C: Pan American Health Organization; 2007.
15.
go back to reference University of York, NHS Centre for Reviews and Dissemination. Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care. York: CRD, University of York; 2009. University of York, NHS Centre for Reviews and Dissemination. Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care. York: CRD, University of York; 2009.
16.
go back to reference Rychetnik L, Frommer M. A Schema for Evaluating Evidence on Public Health Interventions. Melbourne: National Public Health Partnership; 2002. Rychetnik L, Frommer M. A Schema for Evaluating Evidence on Public Health Interventions. Melbourne: National Public Health Partnership; 2002.
17.
go back to reference Centers for Disease Control and Prevention. Introduction to Program Evaluation for Public Health Programs: A Self-Study Guide. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Office of the Director, Office of Strategy and Innovation, Atlanta; 2011. Centers for Disease Control and Prevention. Introduction to Program Evaluation for Public Health Programs: A Self-Study Guide. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Office of the Director, Office of Strategy and Innovation, Atlanta; 2011.
18.
go back to reference Cairns J. Discounting in economic evaluation. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 236–55. Cairns J. Discounting in economic evaluation. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 236–55.
19.
go back to reference Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20:2–15.CrossRefPubMed Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health-care technologies. Health Econ. 2011;20:2–15.CrossRefPubMed
20.
go back to reference Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford Univ Press; 1996. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford Univ Press; 1996.
21.
go back to reference Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2007;16:307–17.CrossRefPubMed Gravelle H, Brouwer W, Niessen L, Postma M, Rutten F. Discounting in economic evaluations: stepping forward towards optimal decision rules. Health Econ. 2007;16:307–17.CrossRefPubMed
22.
go back to reference Lazaro A, Barberan R, Rubio E. The economic evaluation of health programmes: why discount health consequences more than monetary consequences? Appl Econ. 2002;34:339–50.CrossRef Lazaro A, Barberan R, Rubio E. The economic evaluation of health programmes: why discount health consequences more than monetary consequences? Appl Econ. 2002;34:339–50.CrossRef
23.
go back to reference Meltzer DO, Smith PC. Theoretical issues relevant to the economic evaluation of health technologies. In: Pauly MV, McGuire TG, Barros PLP, (eds). Handbook of Health Economics Vol. 2. Amsterdam [etc.]: North Holland; 2012. pp. 433–469. Meltzer DO, Smith PC. Theoretical issues relevant to the economic evaluation of health technologies. In: Pauly MV, McGuire TG, Barros PLP, (eds). Handbook of Health Economics Vol. 2. Amsterdam [etc.]: North Holland; 2012. pp. 433–469.
24.
go back to reference Mogyorosy Z, Smith P. The Main Methodological Issues in Costing Health Care Services: A Literature Review, CHE Research Paper 7. York: Centre for Health Economics; 2005. Mogyorosy Z, Smith P. The Main Methodological Issues in Costing Health Care Services: A Literature Review, CHE Research Paper 7. York: Centre for Health Economics; 2005.
25.
go back to reference Rothgang H, Salomon T. Die ökonomische Evaluation von Gesundheitsförderung und Prävention. In: Kolip P, Müller V, editors. Qualität von Gesundheitsförderung und Prävention. Bern: Verlag Hans Huber; 2009. p. 345–62. Rothgang H, Salomon T. Die ökonomische Evaluation von Gesundheitsförderung und Prävention. In: Kolip P, Müller V, editors. Qualität von Gesundheitsförderung und Prävention. Bern: Verlag Hans Huber; 2009. p. 345–62.
26.
go back to reference Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15:975–81.CrossRefPubMed Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15:975–81.CrossRefPubMed
27.
go back to reference Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 68–93. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 68–93.
28.
go back to reference Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs. Health Econ. 1996;5:13–23.CrossRefPubMed Posnett J, Jan S. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs. Health Econ. 1996;5:13–23.CrossRefPubMed
29.
go back to reference van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care. Eur J Health Econ. 2004;5:36–45.CrossRefPubMed van den Berg B, Brouwer WBF, Koopmanschap MA. Economic valuation of informal care. Eur J Health Econ. 2004;5:36–45.CrossRefPubMed
30.
go back to reference van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos GAM, Rutten F. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62:835–45.CrossRefPubMed van den Berg B, Brouwer W, van Exel J, Koopmanschap M, van den Bos GAM, Rutten F. Economic valuation of informal care: lessons from the application of the opportunity costs and proxy good methods. Soc Sci Med. 2006;62:835–45.CrossRefPubMed
31.
go back to reference van den Berg B, Ferrer-i-Carbonell A. Monetary valuation of informal care: the well-being valuation method. Health Econ. 2007;16:1227–44.CrossRefPubMed van den Berg B, Ferrer-i-Carbonell A. Monetary valuation of informal care: the well-being valuation method. Health Econ. 2007;16:1227–44.CrossRefPubMed
32.
go back to reference Koopmanschap MA, van Exel JNA, van den Berg B, Brouwer WBF. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26:269–80.CrossRefPubMed Koopmanschap MA, van Exel JNA, van den Berg B, Brouwer WBF. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26:269–80.CrossRefPubMed
33.
go back to reference Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–8.CrossRefPubMed Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. 1996;276:1253–8.CrossRefPubMed
34.
go back to reference Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs measurement through quality of life? a response to the recommendation of the Washington panel. Health Econ. 1997;6:253–9.CrossRefPubMed Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs measurement through quality of life? a response to the recommendation of the Washington panel. Health Econ. 1997;6:253–9.CrossRefPubMed
35.
go back to reference Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997;6:511–4.CrossRefPubMed Brouwer WBF, Koopmanschap MA, Rutten FFH. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Econ. 1997;6:511–4.CrossRefPubMed
36.
go back to reference Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 94–112. Sculpher M. The role and estimation of productivity costs in economic evaluation. In: Drummond M, McGuire A, editors. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford: Oxford University Press; 2001. p. 94–112.
37.
go back to reference Koopmanschap M, Burdorf A, Jacob K, Jan Meerding W, Brouwer W, Severens H. Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics. 2005;23:47–54.CrossRefPubMed Koopmanschap M, Burdorf A, Jacob K, Jan Meerding W, Brouwer W, Severens H. Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics. 2005;23:47–54.CrossRefPubMed
38.
go back to reference Claxton K, Walker S, Palmer S, Sculpher M. Appropriate Perspectives for Health Care Decisions (CHE Research Paper No. 54). New York: Centre for Health Economics; 2010. Claxton K, Walker S, Palmer S, Sculpher M. Appropriate Perspectives for Health Care Decisions (CHE Research Paper No. 54). New York: Centre for Health Economics; 2010.
39.
go back to reference Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537–49.CrossRefPubMed Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537–49.CrossRefPubMed
40.
go back to reference Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32:335–44.CrossRefPubMed Krol M, Brouwer W. How to estimate productivity costs in economic evaluations. Pharmacoeconomics. 2014;32:335–44.CrossRefPubMed
41.
go back to reference Rappange DR, van Baal PHM, van Exel NJA, Feenstra TL, Rutten FFH, Brouwer WBF. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics. 2008;26:815–30.CrossRefPubMed Rappange DR, van Baal PHM, van Exel NJA, Feenstra TL, Rutten FFH, Brouwer WBF. Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions? Pharmacoeconomics. 2008;26:815–30.CrossRefPubMed
42.
go back to reference Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997;16:33–64.CrossRefPubMed Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997;16:33–64.CrossRefPubMed
43.
go back to reference van Baal PHM, Feenstra TL, Hoogenveen RT, Ardine de Wit G, Brouwer WBF. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a “perfect” cost–utility ratio. Health Econ. 2007;16:421–33.CrossRefPubMed van Baal PHM, Feenstra TL, Hoogenveen RT, Ardine de Wit G, Brouwer WBF. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a “perfect” cost–utility ratio. Health Econ. 2007;16:421–33.CrossRefPubMed
44.
go back to reference Felder S. Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie. Perspekt Wirtsch Suppl. 2006;7:49–73.CrossRef Felder S. Lebenserwartung, medizinischer Fortschritt und Gesundheitsausgaben: Theorie und Empirie. Perspekt Wirtsch Suppl. 2006;7:49–73.CrossRef
45.
go back to reference Breyer F, Felder S. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying. Health Policy. 2006;75:178–86.CrossRefPubMed Breyer F, Felder S. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying. Health Policy. 2006;75:178–86.CrossRefPubMed
46.
47.
go back to reference Gandjour A. Aging diseases - do they prevent preventive health care from saving costs? Health Econ. 2009;18:355–62.CrossRefPubMed Gandjour A. Aging diseases - do they prevent preventive health care from saving costs? Health Econ. 2009;18:355–62.CrossRefPubMed
48.
go back to reference van Baal PHM, Feenstra TL, Polder JJ, Hoogenveen RT, Brouwer WBF. Economic evaluation and the postponement of health care costs. Health Econ. 2011;20:432–45.CrossRefPubMed van Baal PHM, Feenstra TL, Polder JJ, Hoogenveen RT, Brouwer WBF. Economic evaluation and the postponement of health care costs. Health Econ. 2011;20:432–45.CrossRefPubMed
49.
go back to reference Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ. 2005;24:751–73.CrossRefPubMed Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ. 2005;24:751–73.CrossRefPubMed
50.
go back to reference Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009;4:231.CrossRefPubMed Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009;4:231.CrossRefPubMed
51.
go back to reference Round R, Marshall B, Horton K. Planning for Effective Health Promotion Evaluation. Melbourne: Victorian Government Deptartment of Human Services; 2005. Round R, Marshall B, Horton K. Planning for Effective Health Promotion Evaluation. Melbourne: Victorian Government Deptartment of Human Services; 2005.
52.
go back to reference Rothgang H, Greß S, Niebuhr D, Wasem J. Der Oregon Health Plan : ein Beispiel für “rationale Rationierung”? Sozialer Fortschr Ger Rev Soc Policy. 2004;53:206–19. Rothgang H, Greß S, Niebuhr D, Wasem J. Der Oregon Health Plan : ein Beispiel für “rationale Rationierung”? Sozialer Fortschr Ger Rev Soc Policy. 2004;53:206–19.
53.
go back to reference McGregor M. Cost-utility analysis: Use QALYs only with great caution. Can Med Assoc J. 2003;168:433–4. McGregor M. Cost-utility analysis: Use QALYs only with great caution. Can Med Assoc J. 2003;168:433–4.
54.
go back to reference Nord E, Daniels N, Kamlet M. QALYs: some challenges. Value Health. 2009;12:10–5.CrossRef Nord E, Daniels N, Kamlet M. QALYs: some challenges. Value Health. 2009;12:10–5.CrossRef
55.
go back to reference Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21.CrossRefPubMed Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21.CrossRefPubMed
56.
go back to reference Edlin R, Round J, McCabe C, Sculpher M, Claxton K, Cookson R. Cost-Effectiveness Analysis and Ageism: A Review of the Theoretical Literature. A Report for the Department of Health. Leeds: University of Leeds; 2008. Edlin R, Round J, McCabe C, Sculpher M, Claxton K, Cookson R. Cost-Effectiveness Analysis and Ageism: A Review of the Theoretical Literature. A Report for the Department of Health. Leeds: University of Leeds; 2008.
57.
go back to reference Salomon T, Rothgang H, AGil-Projekt. Gesundheitsökonomische Evaluation bei Leistungen für Senioren: Führen diese zu einer Benachteiligung gesundheitsfördernder und präventiver Maßnahmen? Prävent Gesundheitsförderung. 2011;6:138–44.CrossRef Salomon T, Rothgang H, AGil-Projekt. Gesundheitsökonomische Evaluation bei Leistungen für Senioren: Führen diese zu einer Benachteiligung gesundheitsfördernder und präventiver Maßnahmen? Prävent Gesundheitsförderung. 2011;6:138–44.CrossRef
58.
go back to reference Hickey DA, Barker M, McGee H, O’Boyle C. Measuring health-related quality of life in older patient populations. Pharmacoeconomics. 2005;23:971–93.CrossRefPubMed Hickey DA, Barker M, McGee H, O’Boyle C. Measuring health-related quality of life in older patient populations. Pharmacoeconomics. 2005;23:971–93.CrossRefPubMed
59.
go back to reference Cookson R, Culyer AJ. Measuring overall population health: the use and abuse of QALYs. In: Evidence-based Public Health: Effectiveness and Efficiency. Edited by Killoran A, Kelly MP, editors. Oxford: Oxford University Press; 2010:148–168. Cookson R, Culyer AJ. Measuring overall population health: the use and abuse of QALYs. In: Evidence-based Public Health: Effectiveness and Efficiency. Edited by Killoran A, Kelly MP, editors. Oxford: Oxford University Press; 2010:148–168.
61.
go back to reference Makai P, Brouwer WBF, Koopmanschap MA, Stolk EA, Nieboer AP. Quality of life instruments for economic evaluations in health and social care for older people: a systematic review. Soc Sci Med. 2014;102:83–93.CrossRefPubMed Makai P, Brouwer WBF, Koopmanschap MA, Stolk EA, Nieboer AP. Quality of life instruments for economic evaluations in health and social care for older people: a systematic review. Soc Sci Med. 2014;102:83–93.CrossRefPubMed
62.
go back to reference Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, Peters TJ. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67:874–82.CrossRefPubMed Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, Peters TJ. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67:874–82.CrossRefPubMed
63.
go back to reference Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J. Developing attributes for a generic quality of life measure for older people: Preferences or capabilities? Soc Sci Med. 2006;62:1891–901.CrossRefPubMed Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J. Developing attributes for a generic quality of life measure for older people: Preferences or capabilities? Soc Sci Med. 2006;62:1891–901.CrossRefPubMed
64.
go back to reference Couzner L, Ratcliffe J, Lester L, Flynn T, Crotty M. Measuring and valuing quality of life for public health research: application of the ICECAP-O capability index in the Australian general population. Int J Public Health. 2013;58:367–76.CrossRefPubMed Couzner L, Ratcliffe J, Lester L, Flynn T, Crotty M. Measuring and valuing quality of life for public health research: application of the ICECAP-O capability index in the Australian general population. Int J Public Health. 2013;58:367–76.CrossRefPubMed
65.
go back to reference Davis JC, Liu-Ambrose T, Richardson CG, Bryan S. A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes? Qual Life Res. 2013;22:969–77.CrossRefPubMed Davis JC, Liu-Ambrose T, Richardson CG, Bryan S. A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes? Qual Life Res. 2013;22:969–77.CrossRefPubMed
66.
go back to reference Makai P, Looman W, Adang E, Melis R, Stolk E, Fabbricotti I. Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter? Eur J Health Econ. 2014;16:437–50.CrossRefPubMed Makai P, Looman W, Adang E, Melis R, Stolk E, Fabbricotti I. Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter? Eur J Health Econ. 2014;16:437–50.CrossRefPubMed
67.
go back to reference Makai P, Koopmanschap MA, Brouwer WB, Nieboer AA. A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands. Health Qual Life Outcomes. 2013;11:57.CrossRefPubMedPubMedCentral Makai P, Koopmanschap MA, Brouwer WB, Nieboer AA. A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands. Health Qual Life Outcomes. 2013;11:57.CrossRefPubMedPubMedCentral
68.
go back to reference Makai P, Beckebans F, van Exel J, Brouwer WBF. Quality of Life of Nursing Home Residents with Dementia: Validation of the German Version of the ICECAP-O. PLoS ONE. 2014;9:e92016. doi:10.1371/journal.pone.0092016.CrossRefPubMedPubMedCentral Makai P, Beckebans F, van Exel J, Brouwer WBF. Quality of Life of Nursing Home Residents with Dementia: Validation of the German Version of the ICECAP-O. PLoS ONE. 2014;9:e92016. doi:10.1371/journal.pone.0092016.CrossRefPubMedPubMedCentral
69.
go back to reference NICE (National Institute for Health and Care Excellence). Developing NICE Guidelines: The Manual. Process and methods guides; 2014. NICE (National Institute for Health and Care Excellence). Developing NICE Guidelines: The Manual. Process and methods guides; 2014.
Metadata
Title
Economic evaluation of health promotion for older people-methodological problems and challenges
Authors
Kai Huter
Ewa Kocot
Katarzyna Kissimova-Skarbek
Katarzyna Dubas-Jakóbczyk
Heinz Rothgang
Publication date
01-08-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue Special Issue 5/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1519-y

Other articles of this Special Issue 5/2016

BMC Health Services Research 5/2016 Go to the issue